Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party
- Autori: Tagariello, G.; Castaman, G.; Falanga, A.; Santoro, R.; Napolitano, M.; Storti, S.; Veneri, D.; Basso, M.; Candiotto, L.; Tassinari, C.; Federici, A.; De Stefano, V.
- Anno di pubblicazione: 2016
- Tipologia: Articolo in rivista (Articolo in rivista)
- Parole Chiave: Platelet transfusion
- OA Link: http://hdl.handle.net/10447/191487
Abstract
Following high-dose chemotherapy/bone marrow transplantation, patients are routinely, prophylactically transfused with platelet concentrates (PC) if they have a platelet count 10×10(9)/L or higher in the presence of risk factors for bleeding. However, whether such transfusions are necessary in clinically stable patients with no bleeding, or whether a therapeutic transfusion strategy could be sufficient and safe, is still debated.